HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47012,
"recordsTotal": 47012,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=title&start=44100",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=title&start=43500",
"results": [
{
"registry_id": "NCT05968664",
"publication_url": "https://clinicaltrials.gov/study/NCT05968664",
"title": "Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashwin Viswanathan",
"sponsor_slug": "ashwin-viswanathan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508658",
"publication_url": "https://clinicaltrials.gov/study/NCT06508658",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared to Rituximab Plus Gemcitabine and Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544733",
"publication_url": "https://clinicaltrials.gov/study/NCT06544733",
"title": "An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Virologically Suppressed People With HIV-1",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05696366",
"publication_url": "https://clinicaltrials.gov/study/NCT05696366",
"title": "Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525220",
"publication_url": "https://clinicaltrials.gov/study/NCT06525220",
"title": "A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Recurrent or Metastatic PD-L1+ Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus N.V.",
"sponsor_slug": "merus-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494631",
"publication_url": "https://clinicaltrials.gov/study/NCT06494631",
"title": "Clinical Study to Assess the Safety and Performance of the Xeltis Hemodialysis Access Graft",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xeltis",
"sponsor_slug": "xeltis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027099",
"publication_url": "https://clinicaltrials.gov/study/NCT06027099",
"title": "Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06763315",
"publication_url": "https://clinicaltrials.gov/study/NCT06763315",
"title": "The Efficacy, Safety, and Long-Term Prognosis of Low-Dose Selumetinib in the Treatment of Neurofibromatosis Type 1 Associated Plexiform Neurofibromas in Chinese Children: a Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West China Hospital",
"sponsor_slug": "west-china-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807359",
"publication_url": "https://clinicaltrials.gov/study/NCT06807359",
"title": "Open-label Clinical Phase 1/2 Study to Assess the Safety and Efficacy of the SpectraCure P18 System and Verteporfin for Injection for the Treatment of Primary Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SpectraCure AB",
"sponsor_slug": "spectracure-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773195",
"publication_url": "https://clinicaltrials.gov/study/NCT06773195",
"title": "A Phase 1/2 Study of Combined JAK/ERK Inhibition in Patients With Myelofibrosis",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504381",
"publication_url": "https://clinicaltrials.gov/study/NCT06504381",
"title": "A Phase I/IIa Study to Evaluate the Efficacy of DB107-RRV (Formerly Toca511), Administered to Subjects at Time of Resection and Intravenously Thereafter, in Combination With DB107-FC (Formerly Toca FC) and Radiation Therapy or DB107-FC, Temozolomide (TMZ) and Radiation Therapy in Patients With Newly Diagnosed High Grade Glioma",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743126",
"publication_url": "https://clinicaltrials.gov/study/NCT06743126",
"title": "A Prospective, Multicenter, Open-label, Randomized, Actively Controlled, Parallel-group Phase 3 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of IMA203 Versus Investigator's Choice of Treatment in Patients With Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (ACTengine® IMA203-301)",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immatics US, Inc.",
"sponsor_slug": "immatics-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765317",
"publication_url": "https://clinicaltrials.gov/study/NCT06765317",
"title": "Optimizing Frontline Therapy for DLBCL in Older Adults: A GLOfitamab-based, Response-adapted, Window-stYle Study (GLORY)",
"has_exemption": false,
"start_date": "2025-01-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726122",
"publication_url": "https://clinicaltrials.gov/study/NCT06726122",
"title": "Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment for Facial, Submental and Neck Laxity",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06478017",
"publication_url": "https://clinicaltrials.gov/study/NCT06478017",
"title": "Belatacept With Delayed Tacrolimus Withdrawal Versus Standard-of-Care Tacrolimus in Heart Transplant Recipients (RTB-013)",
"has_exemption": false,
"start_date": "2025-01-29",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672575",
"publication_url": "https://clinicaltrials.gov/study/NCT06672575",
"title": "A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854653",
"publication_url": "https://clinicaltrials.gov/study/NCT06854653",
"title": "An Open-Label, Phase 2 Study of PTX-100 Monotherapy in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.",
"has_exemption": false,
"start_date": "2025-03-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prescient Therapeutics, Ltd.",
"sponsor_slug": "prescient-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470282",
"publication_url": "https://clinicaltrials.gov/study/NCT06470282",
"title": "Phase Ib/II Study of Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy as a Bladder-Sparing Trimodality Therapy in Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06710756",
"publication_url": "https://clinicaltrials.gov/study/NCT06710756",
"title": "A Phase I/IIa Image-Guided, Alpha-Particle Therapy Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in Patients With Solid Tumors That Are Known to be Fibroblast Activation Protein (FAP)-Positive",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06382272",
"publication_url": "https://clinicaltrials.gov/study/NCT06382272",
"title": "Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128602",
"publication_url": "https://clinicaltrials.gov/study/NCT07128602",
"title": "Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction.",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcadia University",
"sponsor_slug": "arcadia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699836",
"publication_url": "https://clinicaltrials.gov/study/NCT06699836",
"title": "A Phase Two Study Evaluating Two Doses of Leronlimab (Pro 140) In Combination With Trifluridine + Tipiracil (TAS-102) + Bevacizumab in Participants With CCR5+, Microsatellite Stable (MSS), Relapsed Refractory Metastatic Colorectal Cancer (mCRC)",
"has_exemption": false,
"start_date": "2025-06-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CytoDyn, Inc.",
"sponsor_slug": "cytodyn-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991114",
"publication_url": "https://clinicaltrials.gov/study/NCT06991114",
"title": "An Open-label Phase 2a Study to Evaluate the Safety and Efficacy of AlloNK®, an Allogeneic Cord Blood-derived NK Cell Therapy, in Combination With Rituximab in Relapsing Forms of B-cell Dependent Rheumatologic Diseases",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Artiva Biotherapeutics, Inc.",
"sponsor_slug": "artiva-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973668",
"publication_url": "https://clinicaltrials.gov/study/NCT06973668",
"title": "A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07148128",
"publication_url": "https://clinicaltrials.gov/study/NCT07148128",
"title": "An Open-label, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumour Activity of WEF-001 in Participants With Advanced KRAS- Mutant Solid Tumours.",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Auricula Biosciences Inc.",
"sponsor_slug": "auricula-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954831",
"publication_url": "https://clinicaltrials.gov/study/NCT06954831",
"title": "Phase 2 Trial of Ultra-Hypofractionated Whole Breast Irradiation With Concomitant Lumpectomy Cavity Boost",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914765",
"publication_url": "https://clinicaltrials.gov/study/NCT06914765",
"title": "A Pilot Study Evaluating the Safety and Efficacy of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adolescents",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05361915",
"publication_url": "https://clinicaltrials.gov/study/NCT05361915",
"title": "A Phase 2 Study of AbiVERtinib in Combination With Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (Maverick Trial)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sorrento Therapeutics, Inc.",
"sponsor_slug": "sorrento-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801015",
"publication_url": "https://clinicaltrials.gov/study/NCT06801015",
"title": "A Randomized, Placebo-Controlled Trial of the Effects of Long-Acting GLP-1 or Dual Incretin (GLP-1 and GIP) Modulation on Gastric Motor Functions",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221500",
"publication_url": "https://clinicaltrials.gov/study/NCT07221500",
"title": "A Single-arm, Phase 2, Open-label, Multicenter Study to Evaluate NX-5948 in Adults With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Previously Exposed to a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a B-cell Lymphoma-2 Inhibitor (BCL-2i)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nurix Therapeutics, Inc.",
"sponsor_slug": "nurix-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107204",
"publication_url": "https://clinicaltrials.gov/study/NCT07107204",
"title": "A Multicenter, Open-label, Single-arm Phase Ib/IIa Clinical Study to Evaluate the Safety and Efficacy of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biotroy Therapeutics",
"sponsor_slug": "biotroy-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107971",
"publication_url": "https://clinicaltrials.gov/study/NCT07107971",
"title": "Drug-Eluting Balloon Treatment Versus Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",
"sponsor_slug": "academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06917313",
"publication_url": "https://clinicaltrials.gov/study/NCT06917313",
"title": "A Randomized Phase II Study to Evaluate the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215598",
"publication_url": "https://clinicaltrials.gov/study/NCT07215598",
"title": "Accuracy of Invisalign Attachments: A Split-Mouth Comparative Study of Optimized and Conventional Designs",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209267",
"publication_url": "https://clinicaltrials.gov/study/NCT07209267",
"title": "Baricitinib Curative Repression of HIV-1",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124559",
"publication_url": "https://clinicaltrials.gov/study/NCT07124559",
"title": "Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847360",
"publication_url": "https://clinicaltrials.gov/study/NCT06847360",
"title": "Home-Based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Pain and Symptom Management Among Young Adults With Irritable Bowel Syndrome (IBS)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220304",
"publication_url": "https://clinicaltrials.gov/study/NCT07220304",
"title": "CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corazon Medical PC",
"sponsor_slug": "corazon-medical-pc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265479",
"publication_url": "https://clinicaltrials.gov/study/NCT07265479",
"title": "A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Organon and Co",
"sponsor_slug": "organon-and-co",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223892",
"publication_url": "https://clinicaltrials.gov/study/NCT07223892",
"title": "A Prospective Controlled Trial Evaluating the Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds: A Stratified Analysis by Wound Etiology and Care Setting",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bardia Anvar",
"sponsor_slug": "bardia-anvar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716021",
"publication_url": "https://clinicaltrials.gov/study/NCT06716021",
"title": "Multi-Center, Placebo-Controlled, Phase 3 Study of Etripamil Nasal Spray (NS) in Patients With Atrial Fibrillation and Rapid Ventricular Rate (RVR)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Milestone Pharmaceuticals Inc.",
"sponsor_slug": "milestone-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216586",
"publication_url": "https://clinicaltrials.gov/study/NCT07216586",
"title": "Comparing Opioid Consumption Following Total Knee Arthroplasty With The Perioperative Administration of Zynrelef Versus Adductor Canal Block",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217678",
"publication_url": "https://clinicaltrials.gov/study/NCT07217678",
"title": "Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224009",
"publication_url": "https://clinicaltrials.gov/study/NCT07224009",
"title": "Phase II Clinical Trial Evaluating the Safety and Efficacy of Low Dose Naltrexone (LDN) for the Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228039",
"publication_url": "https://clinicaltrials.gov/study/NCT07228039",
"title": "A Double-Blind Prospective RCT Assessment of ESP Blocks for Analgesia Following Posterior Spinal Fusion",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237737",
"publication_url": "https://clinicaltrials.gov/study/NCT07237737",
"title": "Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247006",
"publication_url": "https://clinicaltrials.gov/study/NCT07247006",
"title": "Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855043",
"publication_url": "https://clinicaltrials.gov/study/NCT06855043",
"title": "Pilot Randomized Controlled Trial of Late Surfactant Therapy With Budesonide for Prevention of Bronchopulmonary Dysplasia",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05179577",
"publication_url": "https://clinicaltrials.gov/study/NCT05179577",
"title": "A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Investigate the Safety and Efficacy of Arbaclofen Extended-Release Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis (Study OS440-3006)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RVL Pharmaceuticals, Inc.",
"sponsor_slug": "rvl-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02977780",
"publication_url": "https://clinicaltrials.gov/study/NCT02977780",
"title": "INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)",
"has_exemption": false,
"start_date": "2017-02-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Wen, MD",
"sponsor_slug": "patrick-wen-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949099",
"publication_url": "https://clinicaltrials.gov/study/NCT05949099",
"title": "Phase II Study of Cryoablation and Nirogacestat for Desmoid Tumor",
"has_exemption": false,
"start_date": "2023-08-15",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nam Bui",
"sponsor_slug": "nam-bui",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05819853",
"publication_url": "https://clinicaltrials.gov/study/NCT05819853",
"title": "Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05386394",
"publication_url": "https://clinicaltrials.gov/study/NCT05386394",
"title": "Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06127407",
"publication_url": "https://clinicaltrials.gov/study/NCT06127407",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen",
"has_exemption": false,
"start_date": "2024-07-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336655",
"publication_url": "https://clinicaltrials.gov/study/NCT06336655",
"title": "Physiology of Unloading VA ECMO Trial",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06867549",
"publication_url": "https://clinicaltrials.gov/study/NCT06867549",
"title": "Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940180",
"publication_url": "https://clinicaltrials.gov/study/NCT06940180",
"title": "Perioperative Chemoimmunotherapy With Toripalimab for Sinonasal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Glenn J. Hanna",
"sponsor_slug": "glenn-j-hanna",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04433572",
"publication_url": "https://clinicaltrials.gov/study/NCT04433572",
"title": "Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the Incidence of Ischemia-Driven Major Amputation, Clinically Driven Target Lesion Revascularization, and Clinically Relevant Target Lesion Occlusion After Revascularization of Lesions Below the Knee in Patients With Symptomatic Rutherford 3-5 Peripheral Artery Disease",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mercator MedSystems, Inc.",
"sponsor_slug": "mercator-medsystems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445166",
"publication_url": "https://clinicaltrials.gov/study/NCT06445166",
"title": "A Multicenter Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Adults",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07085338",
"publication_url": "https://clinicaltrials.gov/study/NCT07085338",
"title": "A Phase II Study With a Safety Run-In of the Addition of N-803, a Novel IL-15 Super-Agonist, to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07009899",
"publication_url": "https://clinicaltrials.gov/study/NCT07009899",
"title": "BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133425",
"publication_url": "https://clinicaltrials.gov/study/NCT07133425",
"title": "A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-02-05",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205822",
"publication_url": "https://clinicaltrials.gov/study/NCT07205822",
"title": "A Phase IIIb, Open-label, Multinational Study Assessing the Efficacy and Safety of Dato-DXd Treatment in Patients With HRpositive, HER2 IHC 0, Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy (TROPION-Breast06)",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219407",
"publication_url": "https://clinicaltrials.gov/study/NCT07219407",
"title": "An Open-label, Long-term Study Evaluating RAP-219 in Adult Participants With Refractory Onset Seizures",
"has_exemption": false,
"start_date": "2025-11-03",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapport Therapeutics Inc.",
"sponsor_slug": "rapport-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06830798",
"publication_url": "https://clinicaltrials.gov/study/NCT06830798",
"title": "A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223138",
"publication_url": "https://clinicaltrials.gov/study/NCT07223138",
"title": "A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "MoonLake Immunotherapeutics AG",
"sponsor_slug": "moonlake-immunotherapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03173924",
"publication_url": "https://clinicaltrials.gov/study/NCT03173924",
"title": "Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2017-06-06",
"completion_date": "2028-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04771130",
"publication_url": "https://clinicaltrials.gov/study/NCT04771130",
"title": "A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies",
"has_exemption": false,
"start_date": "2021-05-24",
"completion_date": "2028-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04266041",
"publication_url": "https://clinicaltrials.gov/study/NCT04266041",
"title": "High-density EEG in Neurological Disorders",
"has_exemption": false,
"start_date": "2018-02-09",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456463",
"publication_url": "https://clinicaltrials.gov/study/NCT06456463",
"title": "A Phase II Multicenter Open-label Trial of Tagraxofusp (Tag) in Combination With Venetoclax and Azacitidine (Ven/Aza) in Adults With Previously Untreated CD123+ Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219043",
"publication_url": "https://clinicaltrials.gov/study/NCT07219043",
"title": "A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-02-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525636",
"publication_url": "https://clinicaltrials.gov/study/NCT06525636",
"title": "A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia",
"has_exemption": false,
"start_date": "2024-10-09",
"completion_date": "2028-02-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyowa Kirin Co., Ltd.",
"sponsor_slug": "kyowa-kirin-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979323",
"publication_url": "https://clinicaltrials.gov/study/NCT06979323",
"title": "The IMAGINE Study: A Phase 3b Open Label, Single Arm Study to Assess the Effect of Depemokimab on Airway Structure and Function in Asthma With Type 2 Inflammation Characterized by an Eosinophilic Phenotype Utilizing Quantitative High-resolution CT and Bronchoscopic Airway Sampling in a Sub Study",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2028-02-11",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201066",
"publication_url": "https://clinicaltrials.gov/study/NCT05201066",
"title": "An Open-label, Multicenter, Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.",
"has_exemption": false,
"start_date": "2023-02-13",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581198",
"publication_url": "https://clinicaltrials.gov/study/NCT06581198",
"title": "A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients With Active, Refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN).",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311721",
"publication_url": "https://clinicaltrials.gov/study/NCT06311721",
"title": "A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06542250",
"publication_url": "https://clinicaltrials.gov/study/NCT06542250",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With Relapsed or Refractory B-Cell Malignancies (TITANium)",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226882",
"publication_url": "https://clinicaltrials.gov/study/NCT07226882",
"title": "A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF DIFFERENT VACCINATION SCHEDULES OF 6-VALENT OSPA-BASED LYME DISEASE VACCINE, VLA15, IN HEALTHY ADULT PARTICIPANTS",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05363709",
"publication_url": "https://clinicaltrials.gov/study/NCT05363709",
"title": "A Phase 2 Study to Assess the Effect of BALSTILIMAB (AGEN2034) on Viral Clearance in HPV-positive Oropharyngeal Cancer Patients With Persistent HPV Detection in Plasma cfDNA After Definitive Therapy",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06253221",
"publication_url": "https://clinicaltrials.gov/study/NCT06253221",
"title": "A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (Age 12 Years to < 18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747585",
"publication_url": "https://clinicaltrials.gov/study/NCT06747585",
"title": "A Phase I/II, Open-Label, Multicenter Study of ALE.P02 (Claudin-1 Targeted Antibody-Drug Conjugate) as a Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+Squamous Solid Tumors",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alentis Therapeutics AG",
"sponsor_slug": "alentis-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948448",
"publication_url": "https://clinicaltrials.gov/study/NCT06948448",
"title": "A Randomized, Open Label, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo® in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care for First-line Treatment of Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05677971",
"publication_url": "https://clinicaltrials.gov/study/NCT05677971",
"title": "A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706622",
"publication_url": "https://clinicaltrials.gov/study/NCT06706622",
"title": "Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627244",
"publication_url": "https://clinicaltrials.gov/study/NCT06627244",
"title": "Phase 2, Single Arm Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007793",
"publication_url": "https://clinicaltrials.gov/study/NCT07007793",
"title": "A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants With Primary Aldosteronism",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091254",
"publication_url": "https://clinicaltrials.gov/study/NCT06091254",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 X Anti-CD3 Bispecific Antibody Versus Investigator's Choice in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-1)",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-02-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843434",
"publication_url": "https://clinicaltrials.gov/study/NCT06843434",
"title": "A Phase II Study of Neoadjuvant Botensilimab and Balstilimab Immunotherapy for Mismatch Repair Proficient Rectal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439485",
"publication_url": "https://clinicaltrials.gov/study/NCT06439485",
"title": "Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07244263",
"publication_url": "https://clinicaltrials.gov/study/NCT07244263",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-02-06",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04083495",
"publication_url": "https://clinicaltrials.gov/study/NCT04083495",
"title": "Phase II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Peripheral T Cell Lymphoma",
"has_exemption": false,
"start_date": "2019-09-17",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04782258",
"publication_url": "https://clinicaltrials.gov/study/NCT04782258",
"title": "A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 Days to Less Than 18 Years of Age With Autosomal Recessive Polycystic Kidney Disease (ARPKD)",
"has_exemption": false,
"start_date": "2023-01-23",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866405",
"publication_url": "https://clinicaltrials.gov/study/NCT06866405",
"title": "A Phase 3 Study to Investigate the Safety, Tolerability, and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of a Single Dose of a Bivalent Respiratory Syncytial Virus (RSV) Vaccine.",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06795022",
"publication_url": "https://clinicaltrials.gov/study/NCT06795022",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD9793, a T Cell-engaging Antibody Targeting Glypican-3 (GPC3) in Adult Participants With Advanced or Metastatic Solid Tumours (RHEA-1)",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096908",
"publication_url": "https://clinicaltrials.gov/study/NCT07096908",
"title": "Treatment With Tirzepatide of the Disease of Obesity in People With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Dasman Diabetes Institute",
"sponsor_slug": "dasman-diabetes-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06744920",
"publication_url": "https://clinicaltrials.gov/study/NCT06744920",
"title": "A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2028-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03438747",
"publication_url": "https://clinicaltrials.gov/study/NCT03438747",
"title": "An Assessment of P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation",
"has_exemption": false,
"start_date": "2018-04-24",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CeraPedics, Inc",
"sponsor_slug": "cerapedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887715",
"publication_url": "https://clinicaltrials.gov/study/NCT03887715",
"title": "A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "LivaNova",
"sponsor_slug": "livanova",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04610866",
"publication_url": "https://clinicaltrials.gov/study/NCT04610866",
"title": "Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat",
"has_exemption": false,
"start_date": "2020-12-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04931342",
"publication_url": "https://clinicaltrials.gov/study/NCT04931342",
"title": "A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04712539",
"publication_url": "https://clinicaltrials.gov/study/NCT04712539",
"title": "Efficacy of Combination Baloxovir and Oseltamivir Therapy in Influenza Infected Immunocompromised Hosts",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05037760",
"publication_url": "https://clinicaltrials.gov/study/NCT05037760",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination With Ruxolitinib in Participants With Myelofibrosis",
"has_exemption": false,
"start_date": "2021-12-16",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064280",
"publication_url": "https://clinicaltrials.gov/study/NCT05064280",
"title": "Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases",
"has_exemption": false,
"start_date": "2022-01-20",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04966481",
"publication_url": "https://clinicaltrials.gov/study/NCT04966481",
"title": "Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor: A Multicenter, Open-Label, Randomized Phase 3 Trial",
"has_exemption": false,
"start_date": "2022-04-06",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05594992",
"publication_url": "https://clinicaltrials.gov/study/NCT05594992",
"title": "An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects",
"has_exemption": false,
"start_date": "2023-02-22",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "JCR Pharmaceuticals Co., Ltd.",
"sponsor_slug": "jcr-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05816382",
"publication_url": "https://clinicaltrials.gov/study/NCT05816382",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05546554",
"publication_url": "https://clinicaltrials.gov/study/NCT05546554",
"title": "Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06331052",
"publication_url": "https://clinicaltrials.gov/study/NCT06331052",
"title": "3-D Tractography Focused Ultrasound Ablation for Essential Tremor",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564038",
"publication_url": "https://clinicaltrials.gov/study/NCT06564038",
"title": "A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination With Other Anticancer Agents in Participants With Mature B-Cell Malignancies",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964269",
"publication_url": "https://clinicaltrials.gov/study/NCT06964269",
"title": "A Phase 4 Pilot Study With Extension to Assess the Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease and the Effect on Corneal Nerves and Neuropathic Corneal Pain",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Toyos Clinic",
"sponsor_slug": "toyos-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831149",
"publication_url": "https://clinicaltrials.gov/study/NCT06831149",
"title": "A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Matthew Spector",
"sponsor_slug": "matthew-spector",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855498",
"publication_url": "https://clinicaltrials.gov/study/NCT06855498",
"title": "A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810375",
"publication_url": "https://clinicaltrials.gov/study/NCT06810375",
"title": "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819670",
"publication_url": "https://clinicaltrials.gov/study/NCT06819670",
"title": "A Multicenter Pilot Clinical Trial to Prevent Infantile Spasms Relapse",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218679",
"publication_url": "https://clinicaltrials.gov/study/NCT07218679",
"title": "Clinical Trial on the Use of Stratafix Symmetric vs. Resorbable Monofilament for Closure of Large Median Laparotomy in Oncological Patients",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla",
"sponsor_slug": "fundacion-publica-andaluza-para-la-gestion-de-la-investigacion-en-sevilla",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817018",
"publication_url": "https://clinicaltrials.gov/study/NCT06817018",
"title": "Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Leslie Shen",
"sponsor_slug": "leslie-shen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07048262",
"publication_url": "https://clinicaltrials.gov/study/NCT07048262",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 Years) With Non-cystic Fibrosis Bronchiectasis",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04883619",
"publication_url": "https://clinicaltrials.gov/study/NCT04883619",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Nipocalimab in Adult Participants With Active Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704100",
"publication_url": "https://clinicaltrials.gov/study/NCT06704100",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of Fosamprenavir-Sodium Alginate Administered Orally for 8 Weeks to Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02679144",
"publication_url": "https://clinicaltrials.gov/study/NCT02679144",
"title": "NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03093116",
"publication_url": "https://clinicaltrials.gov/study/NCT03093116",
"title": "A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)",
"has_exemption": false,
"start_date": "2017-03-07",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Turning Point Therapeutics, Inc.",
"sponsor_slug": "turning-point-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04524611",
"publication_url": "https://clinicaltrials.gov/study/NCT04524611",
"title": "A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2020-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130450",
"publication_url": "https://clinicaltrials.gov/study/NCT05130450",
"title": "An Open-Label Extension Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)",
"has_exemption": false,
"start_date": "2021-11-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05215340",
"publication_url": "https://clinicaltrials.gov/study/NCT05215340",
"title": "A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects With Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung08)",
"has_exemption": false,
"start_date": "2022-03-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05294588",
"publication_url": "https://clinicaltrials.gov/study/NCT05294588",
"title": "Division of Microbiology and Infectious Diseases, (DMID) 21-0018: Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae",
"has_exemption": false,
"start_date": "2022-04-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05529316",
"publication_url": "https://clinicaltrials.gov/study/NCT05529316",
"title": "A Multicohort, Open Label, Phase 2 Study of Botensilimab (AGEN1181) for Treatment of Advanced Melanoma Refractory to Prior Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2022-12-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Agenus Inc.",
"sponsor_slug": "agenus-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04905914",
"publication_url": "https://clinicaltrials.gov/study/NCT04905914",
"title": "A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of Oral ATRN-119 In Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-01-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Aprea Therapeutics",
"sponsor_slug": "aprea-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05783609",
"publication_url": "https://clinicaltrials.gov/study/NCT05783609",
"title": "A Phase 2 Study of Epcoritamab and Rituximab for First-line Treatment of Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05537896",
"publication_url": "https://clinicaltrials.gov/study/NCT05537896",
"title": "Prospective Evaluation of Xerava™ (Eravacycline) Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260709",
"publication_url": "https://clinicaltrials.gov/study/NCT06260709",
"title": "Open-label Extension Study of Long-term Safety and Efficacy of NNC6019-0001 in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR CM)",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05913388",
"publication_url": "https://clinicaltrials.gov/study/NCT05913388",
"title": "Randomized Double-Blind Placebo Controlled Phase II Study of a Galectin-3 Inhibitor (GB1211) and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191562",
"publication_url": "https://clinicaltrials.gov/study/NCT06191562",
"title": "Randomized Clinical Trial of Post-operative Outcomes Following Posterior Versus Anterior Tympanostomy Tube Placement",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "David Chi, MD",
"sponsor_slug": "david-chi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111781",
"publication_url": "https://clinicaltrials.gov/study/NCT06111781",
"title": "The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384807",
"publication_url": "https://clinicaltrials.gov/study/NCT06384807",
"title": "A Phase 1/2, First in Human, Dose Escalation and Dose Expansion Study of BHV-1510 (Previously PBI-410) as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biohaven Therapeutics Ltd.",
"sponsor_slug": "biohaven-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504147",
"publication_url": "https://clinicaltrials.gov/study/NCT06504147",
"title": "A Phase 2, Randomised, Open Label, Multicentre Study of an Intraperitoneal Α-emitting Radionuclide Therapy (Radspherin®) in Patients with Primary Advanced High-grade Serous or High-grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, with Peritoneal Metastasis That Are Homologous Recombination Proficient and Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery",
"has_exemption": false,
"start_date": "2024-06-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oncoinvent AS",
"sponsor_slug": "oncoinvent-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06496178",
"publication_url": "https://clinicaltrials.gov/study/NCT06496178",
"title": "A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus N.V.",
"sponsor_slug": "merus-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06437574",
"publication_url": "https://clinicaltrials.gov/study/NCT06437574",
"title": "Lowering Cholesterol in Prostate Cancer to Target Rapamycin-Insensitive Companion of MTOR (TORC2) in T-Cell Surface Glycoprotein CD8 Alpha Chain (CD8+) Lymphocytes",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06310031",
"publication_url": "https://clinicaltrials.gov/study/NCT06310031",
"title": "Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BrioHealth Solutions, Inc.",
"sponsor_slug": "briohealth-solutions-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06532656",
"publication_url": "https://clinicaltrials.gov/study/NCT06532656",
"title": "A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1",
"has_exemption": false,
"start_date": "2024-11-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336798",
"publication_url": "https://clinicaltrials.gov/study/NCT06336798",
"title": "Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568939",
"publication_url": "https://clinicaltrials.gov/study/NCT06568939",
"title": "A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092333",
"publication_url": "https://clinicaltrials.gov/study/NCT06092333",
"title": "A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699602",
"publication_url": "https://clinicaltrials.gov/study/NCT06699602",
"title": "A Pilot Phase II Study of Neoadjuvant Cemiplimab + Fianlimab in Patients With Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534060",
"publication_url": "https://clinicaltrials.gov/study/NCT06534060",
"title": "A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).",
"has_exemption": false,
"start_date": "2025-02-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "March Biosciences Inc",
"sponsor_slug": "march-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06860386",
"publication_url": "https://clinicaltrials.gov/study/NCT06860386",
"title": "A Phase II Study Assessing the Feasibility and Clinical Efficacy of Adaptive Immunotherapy Combination With VEGFR-TKI in Patients With Advanced Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824792",
"publication_url": "https://clinicaltrials.gov/study/NCT06824792",
"title": "Real-world Study to Investigate Optimal Standard Treatment Selection for Solid Tumor Patients by Guided by Biologically-informed Multi-agent System",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "NING LI",
"sponsor_slug": "ning-li",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902311",
"publication_url": "https://clinicaltrials.gov/study/NCT06902311",
"title": "Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06522737",
"publication_url": "https://clinicaltrials.gov/study/NCT06522737",
"title": "A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SecuraBio",
"sponsor_slug": "securabio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800963",
"publication_url": "https://clinicaltrials.gov/study/NCT06800963",
"title": "ResQ133A-NMIBC: Phase 1/2 Clinical Trial of Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730283",
"publication_url": "https://clinicaltrials.gov/study/NCT05730283",
"title": "Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Pulmonary Non-Tuberculous Mycobacterium Disease",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kevin Winthrop",
"sponsor_slug": "kevin-winthrop",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995677",
"publication_url": "https://clinicaltrials.gov/study/NCT06995677",
"title": "A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891781",
"publication_url": "https://clinicaltrials.gov/study/NCT06891781",
"title": "A Prospective, Multi-center, Randomized, Double-blind, Cross Over, Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Stimulation in Levodopa- Responsive Parkinson's Disease Treated with Bilateral Deep Brain Stimulation of the Subthalamic Nucleus",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Newronika",
"sponsor_slug": "newronika",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855277",
"publication_url": "https://clinicaltrials.gov/study/NCT06855277",
"title": "A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801639",
"publication_url": "https://clinicaltrials.gov/study/NCT06801639",
"title": "Advancing Alzheimer's Care: Home-based tDCS (Transcranial Direct Current Stimulator) for Affective Symptoms",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055594",
"publication_url": "https://clinicaltrials.gov/study/NCT07055594",
"title": "A Phase I/IIa Dose-escalation, Dose-optimization and Dose Expansion Study to Evaluate the Safety and Preliminary Efficacy of Tri-specific Antibody (SOA101) in Subjects With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Shine-On Biomedical Co., Ltd.",
"sponsor_slug": "shine-on-biomedical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145918",
"publication_url": "https://clinicaltrials.gov/study/NCT07145918",
"title": "An Adaptive Two-part Randomized, Double Blind, Placebo-controlled Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Emraclidine in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029581",
"publication_url": "https://clinicaltrials.gov/study/NCT07029581",
"title": "A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925321",
"publication_url": "https://clinicaltrials.gov/study/NCT06925321",
"title": "An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Basilea Pharmaceutica",
"sponsor_slug": "basilea-pharmaceutica",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521476",
"publication_url": "https://clinicaltrials.gov/study/NCT06521476",
"title": "Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanjay R Patel",
"sponsor_slug": "sanjay-r-patel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201519",
"publication_url": "https://clinicaltrials.gov/study/NCT07201519",
"title": "Phase IIa Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael J Cavnar, MD",
"sponsor_slug": "michael-j-cavnar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221851",
"publication_url": "https://clinicaltrials.gov/study/NCT07221851",
"title": "A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma A/S",
"sponsor_slug": "ascendis-pharma-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743113",
"publication_url": "https://clinicaltrials.gov/study/NCT06743113",
"title": "A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hemanext",
"sponsor_slug": "hemanext",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07170540",
"publication_url": "https://clinicaltrials.gov/study/NCT07170540",
"title": "Cashew Allergy Study in Children: Assessing Desensitization, Efficacy, and Safety (CASCADES Study)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136571",
"publication_url": "https://clinicaltrials.gov/study/NCT07136571",
"title": "Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192731",
"publication_url": "https://clinicaltrials.gov/study/NCT07192731",
"title": "Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191548",
"publication_url": "https://clinicaltrials.gov/study/NCT07191548",
"title": "Treatment of LIVER METastases From Colorectal Cancer by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study.",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114679",
"publication_url": "https://clinicaltrials.gov/study/NCT07114679",
"title": "Molecular Breast Imaging (MBI)-Guided Biopsy Pilot SBIR",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Smart Breast Corp.",
"sponsor_slug": "smart-breast-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404088",
"publication_url": "https://clinicaltrials.gov/study/NCT04404088",
"title": "A Phase II Study of Acalabrutinib, Lenalidomide, and Rituximab (aR2) in Patients With Previously Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-07-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04941274",
"publication_url": "https://clinicaltrials.gov/study/NCT04941274",
"title": "A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05488431",
"publication_url": "https://clinicaltrials.gov/study/NCT05488431",
"title": "Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Priscilla Hsue, MD",
"sponsor_slug": "priscilla-hsue-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05727904",
"publication_url": "https://clinicaltrials.gov/study/NCT05727904",
"title": "A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel (LN-144, Autologous Tumor Infiltrating Lymphocytes [TIL]) Regimen in Combination With Pembrolizumab Compared With Pembrolizumab Monotherapy in Participants With Untreated, Unresectable or Metastatic Melanoma",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05706025",
"publication_url": "https://clinicaltrials.gov/study/NCT05706025",
"title": "Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06633913",
"publication_url": "https://clinicaltrials.gov/study/NCT06633913",
"title": "Neural Effects of Transcranial Magnetic Stimulation Using Concurrent Functional Magnetic Resonance Imaging",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jing Jiang",
"sponsor_slug": "jing-jiang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06275776",
"publication_url": "https://clinicaltrials.gov/study/NCT06275776",
"title": "The Effect of Suturing Techniques on Aberrant Wound Recovery After Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reinier Haga Orthopedisch Centrum",
"sponsor_slug": "reinier-haga-orthopedisch-centrum",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157099",
"publication_url": "https://clinicaltrials.gov/study/NCT06157099",
"title": "A Decentralized Phase II Randomized Controlled Trial of Atorvastatin in Resected High-Risk Melanoma",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06578741",
"publication_url": "https://clinicaltrials.gov/study/NCT06578741",
"title": "GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06398106",
"publication_url": "https://clinicaltrials.gov/study/NCT06398106",
"title": "Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06675344",
"publication_url": "https://clinicaltrials.gov/study/NCT06675344",
"title": "A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Robyn T. Domsic, MD, MPH",
"sponsor_slug": "robyn-t-domsic-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06563596",
"publication_url": "https://clinicaltrials.gov/study/NCT06563596",
"title": "A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592833",
"publication_url": "https://clinicaltrials.gov/study/NCT06592833",
"title": "Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216222",
"publication_url": "https://clinicaltrials.gov/study/NCT07216222",
"title": "Intracranial Recording and Stimulation of the Human Hippocampal-Amygdala Circuit During Virtual Reality Fear Conditioning",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580054",
"publication_url": "https://clinicaltrials.gov/study/NCT06580054",
"title": "Pembrolizumab for Orbital and Periocular Cutaneous Squamous Cell Carcinoma (cSCC)",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377215",
"publication_url": "https://clinicaltrials.gov/study/NCT06377215",
"title": "Understanding Aided Speech Perception in Noise: Behavioral and Electrophysiological Measures",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of South Florida",
"sponsor_slug": "university-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849713",
"publication_url": "https://clinicaltrials.gov/study/NCT06849713",
"title": "A Phase 2 Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959511",
"publication_url": "https://clinicaltrials.gov/study/NCT06959511",
"title": "Neoadjuvant Treatment With Zanzalintinib for Advanced Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06367361",
"publication_url": "https://clinicaltrials.gov/study/NCT06367361",
"title": "Non-inferiority, Controlled, Randomized, Single-blind Study for Compare Regimens of One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole to Treat Chronic Fascioliasis",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Peruana Cayetano Heredia",
"sponsor_slug": "universidad-peruana-cayetano-heredia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05535361",
"publication_url": "https://clinicaltrials.gov/study/NCT05535361",
"title": "A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eclipse Regenesis, Inc.",
"sponsor_slug": "eclipse-regenesis-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07123454",
"publication_url": "https://clinicaltrials.gov/study/NCT07123454",
"title": "A Modular Phase I/II Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Efficacy of AZD4512 Monotherapy or in Combination With Other Anticancer Agent(s), in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) (Lumi-NHL)",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934239",
"publication_url": "https://clinicaltrials.gov/study/NCT06934239",
"title": "A Randomized Controlled Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07025330",
"publication_url": "https://clinicaltrials.gov/study/NCT07025330",
"title": "A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204080",
"publication_url": "https://clinicaltrials.gov/study/NCT07204080",
"title": "Phase II Clinical Trial Evaluating the Safety and Efficacy of Fc-Modified Anti-CD154 mAB (TNX-1500) in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayman Al Jurdi, MD",
"sponsor_slug": "ayman-al-jurdi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07251491",
"publication_url": "https://clinicaltrials.gov/study/NCT07251491",
"title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "James J. Peters Veterans Affairs Medical Center",
"sponsor_slug": "james-j-peters-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215858",
"publication_url": "https://clinicaltrials.gov/study/NCT07215858",
"title": "Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of the Safety and Efficacy of BPL-1357 Against H1N1 Influenza Virus Challenge",
"has_exemption": false,
"start_date": "2026-03-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06210854",
"publication_url": "https://clinicaltrials.gov/study/NCT06210854",
"title": "Double-Blind Randomized Phase II Clinical Trial Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03571945",
"publication_url": "https://clinicaltrials.gov/study/NCT03571945",
"title": "Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sir Ganga Ram Hospital",
"sponsor_slug": "sir-ganga-ram-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05682378",
"publication_url": "https://clinicaltrials.gov/study/NCT05682378",
"title": "An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Have Completed the Adolescent ORION-16 or ORION-13 Studies (VICTORION-PEDS-OLE)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05732402",
"publication_url": "https://clinicaltrials.gov/study/NCT05732402",
"title": "An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3)",
"has_exemption": false,
"start_date": "2023-03-15",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpine Immune Sciences, Inc.",
"sponsor_slug": "alpine-immune-sciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06268873",
"publication_url": "https://clinicaltrials.gov/study/NCT06268873",
"title": "A Phase III, Randomised, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants With CKD and High Blood Pressure",
"has_exemption": false,
"start_date": "2024-03-29",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06676579",
"publication_url": "https://clinicaltrials.gov/study/NCT06676579",
"title": "A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05402332",
"publication_url": "https://clinicaltrials.gov/study/NCT05402332",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG)",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva Morava-Kozicz",
"sponsor_slug": "eva-morava-kozicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05834296",
"publication_url": "https://clinicaltrials.gov/study/NCT05834296",
"title": "Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 1/2a Study to Assess Safety, Tolerability & Efficacy of Autologous Beta-Amyloid Mutant Peptide-pulsed Dendritic Cells in Subjects With Mild-to-Moderate Alzheimer's Dementia",
"has_exemption": false,
"start_date": "2023-07-05",
"completion_date": "2028-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Alzamend Neuro, Inc.",
"sponsor_slug": "alzamend-neuro-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375800",
"publication_url": "https://clinicaltrials.gov/study/NCT04375800",
"title": "A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Participants With HIV-1, Who Are 4 Weeks to Less Than 12 Years of Age and Weigh Less Than 45 kg",
"has_exemption": false,
"start_date": "2021-02-03",
"completion_date": "2028-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06283966",
"publication_url": "https://clinicaltrials.gov/study/NCT06283966",
"title": "A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)",
"has_exemption": false,
"start_date": "2024-02-21",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928662",
"publication_url": "https://clinicaltrials.gov/study/NCT06928662",
"title": "Sequential Decitabine in Combination With FLAG-Ida Followed Immediately by Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (DEC-FLAG-Ida/RIC) for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1/2 Study",
"has_exemption": false,
"start_date": "2025-09-23",
"completion_date": "2028-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04276870",
"publication_url": "https://clinicaltrials.gov/study/NCT04276870",
"title": "CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)",
"has_exemption": false,
"start_date": "2020-03-12",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephan Grupp MD PhD",
"sponsor_slug": "stephan-grupp-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144280",
"publication_url": "https://clinicaltrials.gov/study/NCT07144280",
"title": "A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY TO EVALUATE PF-08046054/SGN-PDLlV VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLY-TREATED PROGRAMMED CELL DEATH LIGAND 1 (PD-Ll) POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC)",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06403644",
"publication_url": "https://clinicaltrials.gov/study/NCT06403644",
"title": "Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices",
"has_exemption": false,
"start_date": "2024-03-11",
"completion_date": "2028-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "United States Air Force Research Laboratory",
"sponsor_slug": "united-states-air-force-research-laboratory",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926868",
"publication_url": "https://clinicaltrials.gov/study/NCT06926868",
"title": "A Randomized, Open-label, Inferentially Seamless Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable,or Metastatic Triple-negative Breast Cancer (TNBC)or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment",
"has_exemption": false,
"start_date": "2025-09-11",
"completion_date": "2028-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453044",
"publication_url": "https://clinicaltrials.gov/study/NCT06453044",
"title": "A Phase 2 Study of Mosunetuzumab With Polatuzumab Vedotin in Patients With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06245109",
"publication_url": "https://clinicaltrials.gov/study/NCT06245109",
"title": "Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2024-02-26",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616766",
"publication_url": "https://clinicaltrials.gov/study/NCT06616766",
"title": "A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, PK and Anti-tumor Activity of YH42946 in Patients With Locally Advanced or Metastatic Solid Tumors With HER2 Aberration and EGFR Exon 20 Insertion",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Yuhan Corporation",
"sponsor_slug": "yuhan-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06605105",
"publication_url": "https://clinicaltrials.gov/study/NCT06605105",
"title": "A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Cybin IRL Limited",
"sponsor_slug": "cybin-irl-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747611",
"publication_url": "https://clinicaltrials.gov/study/NCT06747611",
"title": "Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06495125",
"publication_url": "https://clinicaltrials.gov/study/NCT06495125",
"title": "A Phase 2 Study of Defactinib and Avutometinib, in Combination With Nivolumab for Patients With Anti-PD1 Refractory LKB1-Mutant Advanced Lung Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305247",
"publication_url": "https://clinicaltrials.gov/study/NCT06305247",
"title": "An Open-label, Phase I/IIa First-in-human, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Antitumour Activity of ERK1/2 Inhibitor IPN01194 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2028-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05160922",
"publication_url": "https://clinicaltrials.gov/study/NCT05160922",
"title": "CRIZOTINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED CRIZOTINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2021-12-27",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04804553",
"publication_url": "https://clinicaltrials.gov/study/NCT04804553",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)",
"has_exemption": false,
"start_date": "2022-03-17",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350097",
"publication_url": "https://clinicaltrials.gov/study/NCT06350097",
"title": "A Phase III, Open-label, Randomised Study of Osimertinib With or Without Datopotamab Deruxtecan (Dato-DXd), as First-line Treatment in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597019",
"publication_url": "https://clinicaltrials.gov/study/NCT06597019",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children (6 to Less Than 12 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL- Cholesterol",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597006",
"publication_url": "https://clinicaltrials.gov/study/NCT06597006",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221188",
"publication_url": "https://clinicaltrials.gov/study/NCT07221188",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213973",
"publication_url": "https://clinicaltrials.gov/study/NCT07213973",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2025-12-14",
"completion_date": "2028-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616910",
"publication_url": "https://clinicaltrials.gov/study/NCT05616910",
"title": "Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06939348",
"publication_url": "https://clinicaltrials.gov/study/NCT06939348",
"title": "Safety and Efficacy of Thalamic Focused Ultrasound Stimulation (tFUS) for Promoting Recovery After Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-26",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136181",
"publication_url": "https://clinicaltrials.gov/study/NCT07136181",
"title": "A Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novelwise Pharmaceutical Corporation",
"sponsor_slug": "novelwise-pharmaceutical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221227",
"publication_url": "https://clinicaltrials.gov/study/NCT07221227",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2028-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05316155",
"publication_url": "https://clinicaltrials.gov/study/NCT05316155",
"title": "Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants With Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2022-04-11",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05811364",
"publication_url": "https://clinicaltrials.gov/study/NCT05811364",
"title": "The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease",
"has_exemption": false,
"start_date": "2023-10-17",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091865",
"publication_url": "https://clinicaltrials.gov/study/NCT06091865",
"title": "A Phase 3, Open Label, Randomized Study Comparing the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 × Anti-CD3 Bispecific Antibody, in Combination With CHOP (ODRO-CHOP) Versus Rituximab in Combination With CHOP (R-CHOP) in Previously Untreated Participants With Diffuse Large B-cell Lymphoma (DLBCL) (OLYMPIA-3)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06213324",
"publication_url": "https://clinicaltrials.gov/study/NCT06213324",
"title": "Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644768",
"publication_url": "https://clinicaltrials.gov/study/NCT06644768",
"title": "A Multicenter, Randomized, Open-Label, Phase 1b/2 Trial Of Valemetostat Tosylate Plus Pembrolizumab Vs Pembrolizumab Alone in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Tumor Proportion Score ≥50% Without Actionable Genomic Alterations",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06565507",
"publication_url": "https://clinicaltrials.gov/study/NCT06565507",
"title": "A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group",
"has_exemption": false,
"start_date": "2024-12-15",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Peruana Cayetano Heredia",
"sponsor_slug": "universidad-peruana-cayetano-heredia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06877650",
"publication_url": "https://clinicaltrials.gov/study/NCT06877650",
"title": "A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of JMT108 Injection in Participants With Advanced Malignant Tumors.",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai JMT-Bio Inc.",
"sponsor_slug": "shanghai-jmt-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06905054",
"publication_url": "https://clinicaltrials.gov/study/NCT06905054",
"title": "Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169175",
"publication_url": "https://clinicaltrials.gov/study/NCT07169175",
"title": "A Multicenter, Open-label, Single-arm, Dose Escalation and Expansion, Phase I/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SNUG01 in Adult Subjects With Amyotrophic Lateral Sclerosis (ALS)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SineuGene Therapeutics Co., Ltd.",
"sponsor_slug": "sineugene-therapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03514329",
"publication_url": "https://clinicaltrials.gov/study/NCT03514329",
"title": "Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Definitive Treatment Study",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Uptake Medical Technology, Inc.",
"sponsor_slug": "uptake-medical-technology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03414502",
"publication_url": "https://clinicaltrials.gov/study/NCT03414502",
"title": "Treatment of Rheumatoid Arthritis With Disease-modifying Antirheumatic Drugs (DMARDs): Predictors of Response",
"has_exemption": false,
"start_date": "2007-12-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02710968",
"publication_url": "https://clinicaltrials.gov/study/NCT02710968",
"title": "Study of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2015-08-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02742883",
"publication_url": "https://clinicaltrials.gov/study/NCT02742883",
"title": "A Phase 2 Study of Atengenal (A-10) and Astugenal (AS2-1) in Diffuse, Intrinsic Pontine Glioma (DIPG)",
"has_exemption": false,
"start_date": "2016-04-13",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Burzynski Research Institute",
"sponsor_slug": "burzynski-research-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03682289",
"publication_url": "https://clinicaltrials.gov/study/NCT03682289",
"title": "Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2019-01-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04261712",
"publication_url": "https://clinicaltrials.gov/study/NCT04261712",
"title": "An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)",
"has_exemption": false,
"start_date": "2019-01-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03865290",
"publication_url": "https://clinicaltrials.gov/study/NCT03865290",
"title": "Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia",
"has_exemption": false,
"start_date": "2019-04-02",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998254",
"publication_url": "https://clinicaltrials.gov/study/NCT03998254",
"title": "A Phase 3 Randomized, Double-Blinded, Controlled With GARDASIL® Efficacy, Immunogenicity and Safety Study of V503 [a 9-Valent HPV Vaccine] in Chinese Women 20 to 45 Years of Age",
"has_exemption": false,
"start_date": "2019-06-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04560803",
"publication_url": "https://clinicaltrials.gov/study/NCT04560803",
"title": "Using Autologous Epidermal Skin Micrografts to Improve Healing In Radiation Wounds: A Pilot Study",
"has_exemption": false,
"start_date": "2021-01-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04696029",
"publication_url": "https://clinicaltrials.gov/study/NCT04696029",
"title": "Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04848506",
"publication_url": "https://clinicaltrials.gov/study/NCT04848506",
"title": "A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment With Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04486833",
"publication_url": "https://clinicaltrials.gov/study/NCT04486833",
"title": "A Phase 1/2 Open-Label, Dose-Escalation and Clinical Response Study of Quaratusugene Ozeplasmid in Combination With Osimertinib in Patients With Advanced, Metastatic EGFR-Mutant, Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2021-09-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genprex, Inc.",
"sponsor_slug": "genprex-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05150704",
"publication_url": "https://clinicaltrials.gov/study/NCT05150704",
"title": "Single Blind Randomized Controlled Trial to Assess the Safety and Efficacy of High Dose Pulse Intravenous Corticosteroid Therapy to Treat Patients With Complicated/Fulminant Acute Myocarditis",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Niguarda Hospital",
"sponsor_slug": "niguarda-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04982419",
"publication_url": "https://clinicaltrials.gov/study/NCT04982419",
"title": "Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04853251",
"publication_url": "https://clinicaltrials.gov/study/NCT04853251",
"title": "A Phase IV, Multicenter, Open-label Study to Assess Corneal Endothelial Cells in Patients With Neovascular Age-related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS)",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04840602",
"publication_url": "https://clinicaltrials.gov/study/NCT04840602",
"title": "A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenström's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL)",
"has_exemption": false,
"start_date": "2022-01-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04977180",
"publication_url": "https://clinicaltrials.gov/study/NCT04977180",
"title": "Phase II Trial of Cardioprotective Prophylaxis With Combination of Beta Blocker and Angiotensin-Converting Enzyme Inhibitors During Intensive Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2022-03-04",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04928846",
"publication_url": "https://clinicaltrials.gov/study/NCT04928846",
"title": "A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2022-03-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05376267",
"publication_url": "https://clinicaltrials.gov/study/NCT05376267",
"title": "Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)",
"has_exemption": false,
"start_date": "2022-08-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05623020",
"publication_url": "https://clinicaltrials.gov/study/NCT05623020",
"title": "MAGNETISMM-6: AN OPEN-LABEL, 2-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) + DARATUMUMAB + LENALIDOMIDE OR ELRANATAMAB + LENALIDOMIDE VERSUS DARATUMUMAB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PARTICIPANTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA",
"has_exemption": false,
"start_date": "2022-11-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05549297",
"publication_url": "https://clinicaltrials.gov/study/NCT05549297",
"title": "Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination With Pembrolizumab Versus Investigator's Choice in HLA-A*02:01-positive Participants With Previously Treated Advanced Melanoma (TEBE-AM)",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunocore Ltd",
"sponsor_slug": "immunocore-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05711394",
"publication_url": "https://clinicaltrials.gov/study/NCT05711394",
"title": "A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6-17 Years of Age.",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05889182",
"publication_url": "https://clinicaltrials.gov/study/NCT05889182",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05871372",
"publication_url": "https://clinicaltrials.gov/study/NCT05871372",
"title": "Intracranial Investigation of Neural Circuity Underlying Human Mood",
"has_exemption": false,
"start_date": "2023-07-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796440",
"publication_url": "https://clinicaltrials.gov/study/NCT05796440",
"title": "An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06019949",
"publication_url": "https://clinicaltrials.gov/study/NCT06019949",
"title": "Neuromodulatory Rehabilitation for Respiratory Motor Function in Individuals With Chronic Spinal Cord Injury",
"has_exemption": false,
"start_date": "2023-09-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05848713",
"publication_url": "https://clinicaltrials.gov/study/NCT05848713",
"title": "AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Manitoba",
"sponsor_slug": "university-of-manitoba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06001918",
"publication_url": "https://clinicaltrials.gov/study/NCT06001918",
"title": "Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nectero Medical, Inc.",
"sponsor_slug": "nectero-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608408",
"publication_url": "https://clinicaltrials.gov/study/NCT05608408",
"title": "Network Neuro-modulation for Mesial Temporal Lobe Epilepsy",
"has_exemption": false,
"start_date": "2023-11-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nitin Tandon",
"sponsor_slug": "nitin-tandon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06149403",
"publication_url": "https://clinicaltrials.gov/study/NCT06149403",
"title": "A Multi-center, Randomized, Active Controlled Clinical Trial to Evaluate the Efficacy and Safety of OTL-203 in Subjects With Mucopolysaccharidosis Type I, Hurler Syndrome (MPS-IH) Compared to Standard of Care With Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orchard Therapeutics",
"sponsor_slug": "orchard-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100641",
"publication_url": "https://clinicaltrials.gov/study/NCT05100641",
"title": "Randomized Phase 3 Trial of Standard Care Plus AV-GBM-1 vs Autologous Monocytes as Adjunctive Therapy Following Primary Surgery Plus Concurrent Radiation-temozolomide in Patients With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aivita Biomedical, Inc.",
"sponsor_slug": "aivita-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06108934",
"publication_url": "https://clinicaltrials.gov/study/NCT06108934",
"title": "A Prospective, Pre-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia Hip Stem in Total Hip Arthroplasty (THA)",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Australia Pty Ltd.",
"sponsor_slug": "stryker-australia-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06223867",
"publication_url": "https://clinicaltrials.gov/study/NCT06223867",
"title": "Evaluation of Efficacy, Effectiveness, and Implementation of Jaspr Health's Digital Platform in Emergency Department for Patients with Suicidal Risk- Part A: Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-23",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06309264",
"publication_url": "https://clinicaltrials.gov/study/NCT06309264",
"title": "Benefits of Speech-based Audiometry and Low-gain Hearing Aids for Blast-exposed Veterans",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05823532",
"publication_url": "https://clinicaltrials.gov/study/NCT05823532",
"title": "Targeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients With Schizophrenia Using an Anti-Inflammatory Challenge.",
"has_exemption": false,
"start_date": "2024-04-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107062",
"publication_url": "https://clinicaltrials.gov/study/NCT06107062",
"title": "Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861986",
"publication_url": "https://clinicaltrials.gov/study/NCT05861986",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Patients With Spinal Muscular Atrophy After Gene Therapy",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06388889",
"publication_url": "https://clinicaltrials.gov/study/NCT06388889",
"title": "An Open-Label Long-Term Phase III Extension Study to Assess the Long-Term Safety and Tolerability of Dexpramipexole in Participants With Severe Eosinophilic Asthma",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Areteia Therapeutics",
"sponsor_slug": "areteia-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483334",
"publication_url": "https://clinicaltrials.gov/study/NCT06483334",
"title": "A Phase 1/2 Randomized, Umbrella Study to Evaluate the Efficacy and Safety of MK-2870 Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab, as Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04C",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428019",
"publication_url": "https://clinicaltrials.gov/study/NCT06428019",
"title": "A Prospective, Open-Label, Phase IIb/III Study to Evaluate the Risk of TLS and Optimization of the Initiation of Venetoclax in Combination With Obinutuzumab or Acalabrutinib With Different Ramp- Up Periods in Previously Untreated Subjects With CLL",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06442566",
"publication_url": "https://clinicaltrials.gov/study/NCT06442566",
"title": "Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)",
"has_exemption": false,
"start_date": "2024-08-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861999",
"publication_url": "https://clinicaltrials.gov/study/NCT05861999",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06033950",
"publication_url": "https://clinicaltrials.gov/study/NCT06033950",
"title": "A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Colorado Prevention Center",
"sponsor_slug": "colorado-prevention-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06096116",
"publication_url": "https://clinicaltrials.gov/study/NCT06096116",
"title": "Phase 3, Double-blind, Placebo-controlled, Multicentre Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass",
"has_exemption": false,
"start_date": "2024-08-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Octapharma",
"sponsor_slug": "octapharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667701",
"publication_url": "https://clinicaltrials.gov/study/NCT05667701",
"title": "Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajesh Kumar",
"sponsor_slug": "rajesh-kumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184750",
"publication_url": "https://clinicaltrials.gov/study/NCT06184750",
"title": "Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction (RENAISSANCE): A Phase II Single Arm Trial",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679270",
"publication_url": "https://clinicaltrials.gov/study/NCT06679270",
"title": "An Open-label Extension of APG-20 Study to Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amryt Pharma",
"sponsor_slug": "amryt-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04530058",
"publication_url": "https://clinicaltrials.gov/study/NCT04530058",
"title": "The Effects of Metformin on Morbidity and Mortality in Elderly Patients- a Prospective Randomized Control Trial (RCT)",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06272812",
"publication_url": "https://clinicaltrials.gov/study/NCT06272812",
"title": "A Phase 2b, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine, MTBVAC, Against TB Disease in Interferon Gamma Release Assay Positive Adolescents and Adults Aged 14-45 Years, Living in a TB Endemic Region.",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "International AIDS Vaccine Initiative",
"sponsor_slug": "international-aids-vaccine-initiative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855212",
"publication_url": "https://clinicaltrials.gov/study/NCT06855212",
"title": "A Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06830044",
"publication_url": "https://clinicaltrials.gov/study/NCT06830044",
"title": "A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06070012",
"publication_url": "https://clinicaltrials.gov/study/NCT06070012",
"title": "Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311214",
"publication_url": "https://clinicaltrials.gov/study/NCT06311214",
"title": "Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06812832",
"publication_url": "https://clinicaltrials.gov/study/NCT06812832",
"title": "Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Madigan Army Medical Center",
"sponsor_slug": "madigan-army-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820463",
"publication_url": "https://clinicaltrials.gov/study/NCT06820463",
"title": "A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06579196",
"publication_url": "https://clinicaltrials.gov/study/NCT06579196",
"title": "Evaluation of Trabedersen (OT-101) With Pembrolizumab in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer and Positive PD-L1",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702553",
"publication_url": "https://clinicaltrials.gov/study/NCT06702553",
"title": "Effect of Inhaled Nitric Oxide on Major Adverse Events Requiring Intensive Life Support in Adults Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Phase III, Double-Blind, Multicenter, Randomized Controlled Trial (Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass, the NORISC Trial)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xijing Hospital",
"sponsor_slug": "xijing-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06485843",
"publication_url": "https://clinicaltrials.gov/study/NCT06485843",
"title": "An Open Label Phase IIb Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ageless Biotech, Inc.",
"sponsor_slug": "ageless-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06682988",
"publication_url": "https://clinicaltrials.gov/study/NCT06682988",
"title": "A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06340568",
"publication_url": "https://clinicaltrials.gov/study/NCT06340568",
"title": "A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075718",
"publication_url": "https://clinicaltrials.gov/study/NCT07075718",
"title": "Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Glaukos Corporation",
"sponsor_slug": "glaukos-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872684",
"publication_url": "https://clinicaltrials.gov/study/NCT06872684",
"title": "Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Neurovascular",
"sponsor_slug": "stryker-neurovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951594",
"publication_url": "https://clinicaltrials.gov/study/NCT06951594",
"title": "Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045909",
"publication_url": "https://clinicaltrials.gov/study/NCT07045909",
"title": "A Phase 2, Open-label, Multicenter Multi-cohort Study to Evaluate the Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06356155",
"publication_url": "https://clinicaltrials.gov/study/NCT06356155",
"title": "A Phase II, Open-label, Single-arm, Multi-center Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer (NEPTUNE)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}